Mark Frohlich Net Worth & Insider Trades

Mark Frohlich - See Remarks, Juno Therapeutics, Inc

As of March 2, 2016

What is Mark Frohlich's Net Worth?

The current estimated net worth of Juno Therapeutics, Inc's See Remarks, Mark Frohlich, is estimated to be about $33.14M . Mark Frohlich owns about 919,583 units of Juno Therapeutics, Inc common stock. In the last year at Juno Therapeutics, Inc, Mark Frohlich has sold an estimated value of $705.34K worth.

What is Mark Frohlich's Past Insider Trading?

Mark Frohlich's largest sale order was 20,000 units , worth over $705.34K on March 2, 2016. In total, Mark Frohlich has made about 3 transactions over a year of their time at Juno Therapeutics, Inc. Mark Frohlich usually trades in March, with the busiest year in 2016.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Mark Frohlich

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Mark Frohlich's' Mailing Address?

  • Mailing address is 3005 First Avenue Seattle WA 98121 WA

What are Juno Therapeutics, Inc's Past Insider Trades?

Juno Therapeutics, Inc's most recent insider trade came on February 14, 2018 by Robert Azelby who sold 4,157 units worth $355.63K . In the last 3 years, insiders at Juno Therapeutics, Inc have sold an estimated value of $1.97B and bought an estimated value of $11.52M worth of shares. Insider trading is most common in June, with the busiest year in 2017. The most active traders at the company are Richard Klausner, Director,  Anthony Evnin, Director,  and Bernard Cassidy, General Counsel & Secretary .

Juno Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...